Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the infasurf market right now?

In the past few years, the infasurf market size has experienced XX (HCAGR). It is anticipated to expand from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. Factors attributing to this growth during the historic period include surge in premature births, enhancements in healthcare infrastructure, increased awareness regarding respiratory illnesses, growth in birth rates, and various government schemes aimed at decreasing child mortality rates.

How fast Is the infasurf market expected to grow, and what’s its future value?

Expectations indicate that the infasurf market size will witness an XX (FCAGR) growth over the coming years. By 2029, it is predicted to expand to an estimated value of $XX million, following a compound annual growth rate (CAGR) of XX%. This predicted surge during the forecasted period is being allotted to factors such as the growing adoption of personalized medicine, increment in air pollution, rising cases of neonatal respiratory ailments, an amplified emphasis on preventive care, along with quick-paced urbanization. The forecast period will also showcase major trends such as XXX.

Get your infasurf market report here!

https://www.thebusinessresearchcompany.com/report/infasurf-global-market-report

What are the leading drivers of growth in the infasurf market?

The infasurf market is likely to experience an upturn due to the increasingly common instance of premature births. Premature or preterm birth refers to a baby being born prior to 37 weeks of gestation, compared to the average 40 weeks for a full-term pregnancy. This condition poses several health threats to the newborn, including respiratory problems, developmental lags, and a heightened risk of sustained disabilities. The uptick in premature births can be linked to various elements, such as advanced maternal age, an increase in multiple pregnancies due to fertility treatments, and the effect of chronic diseases and infections during pregnancy. Infasurf (calfactant) is given directly into the lungs of preterm babies to avert or manage respiratory distress syndrome (RDS) by lessening surface tension and bolstering lung function. For example, a study from the University of Bristol, UK, published in October 2024, discovered that approximately one in 13 births is premature, adding up to more than 50,000 cases each year. Despite measures to prevent preterm birth among women at risk, the preterm birth rates are still on an upward trajectory. Additionally, data from the March of Dimes, a US nonprofit organization, depicted that there were 373,902 premature births in the United States in 2023, making up 10.4% of all live births in March 2024. Hence, the increased incidence of premature births fuels the growth of the infasurf market.

What are the key segments defining the infasurf market?

The infasurf market covered in this report is segmented –

1) By Patient Demographics: Premature Infants, Full-Term Infants, Age Groups

2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Pharmacies

3) By Application: Neonatal Respiratory Distress Syndrome, Other Respiratory Conditions

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20100&type=smp

Who are the key players steering the development of the infasurf market?

Major companies operating in the infasurf market include ONY Biotech Inc.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20100

Which regions are most influential in expanding the infasurf market?

North America was the largest region in the infasurf market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infasurf market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Respiratory Disease Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report

Acute Respiratory Distress Syndrome Global Market Report 2025

https://www.thebusinessresearchcompany.com/sample_request?id=13005&type=smp

Severe Acute Respiratory-Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/severe-acute-respiratory-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: